These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1396350)
1. Altered secretion of corticosteroids and prolactin in adrenal regeneration hypertensive rats. Mimou N; Takeda R Endocrinol Jpn; 1992 Apr; 39(2):185-96. PubMed ID: 1396350 [TBL] [Abstract][Full Text] [Related]
2. [Studies on the renin-angiotensin system in adrenal regeneration hypertension (author's transl)]. Hasatani K Nihon Naibunpi Gakkai Zasshi; 1975 Apr; 51(4):217-27. PubMed ID: 1171793 [TBL] [Abstract][Full Text] [Related]
3. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone. Witzgall H; Thayil G; Weber PC Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560 [TBL] [Abstract][Full Text] [Related]
4. Role of adrenal steroidogenesis in etiology of hypertension in the spontaneously hypertensive rat. Komanicky P; Reiss DL; Dale SL; Melby JC Endocrinology; 1982 Jul; 111(1):219-24. PubMed ID: 7084111 [TBL] [Abstract][Full Text] [Related]
5. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism]. Chamontin B; Blanchouin-Emeric N; Amar J; Khatibi F; Vernier I; Bennet A; Aupetit-Faisant B; Salvador M Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378 [TBL] [Abstract][Full Text] [Related]
6. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism]. Shimizu Y Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468 [TBL] [Abstract][Full Text] [Related]
7. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism. Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061 [TBL] [Abstract][Full Text] [Related]
8. Response of several adrenal steroids to ACTH stimulation in essential hypertension. Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252 [TBL] [Abstract][Full Text] [Related]
9. The relative importance of glucocorticoids and mineralocorticoids in the development of adrenal regeneration hypertension in rats. Kenyon CJ; Clark SA; Hannah JA; Holloway CD; Ingram MC; Lindop G; Towrie A; Ball SG Acta Endocrinol (Copenh); 1986 Jul; 112(3):389-95. PubMed ID: 3019053 [TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. Witzgall H; von Werder K; Weber PC J Steroid Biochem; 1983 Nov; 19(5):1671-6. PubMed ID: 6645503 [TBL] [Abstract][Full Text] [Related]
11. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375 [TBL] [Abstract][Full Text] [Related]
12. Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats. Rapp JP; Tan SY; Margolius HS Endocr Res Commun; 1978; 5(1):35-41. PubMed ID: 710365 [TBL] [Abstract][Full Text] [Related]
13. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension. Griffing GT; Dale SL; Holbrook MM; Melby JC Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221 [TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity. Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073 [TBL] [Abstract][Full Text] [Related]
15. Influence of adrenal enucleation of plasma renin substrate concentration in saline loaded and unilaterally nephroadrenalectomized rats. Morimoto S; Hasatani K; Uchida K; Takeda R Endocrinology; 1975 May; 96(5):1314-9. PubMed ID: 1122891 [TBL] [Abstract][Full Text] [Related]
16. Plasma renin activity (PRA) and plasma aldosterone in the adrenal cortex hyperactivity. Studies on 50 hypertensive patients. Augustin M; Dumitriu L; Ioaniţiu D; Popovici D; Gabrielescu-Berceanu A; Mănciulescu D; Marinescu I; Mazilu M; Dinulescu E; Tache A Endocrinologie; 1984; 22(1):37-45. PubMed ID: 6369502 [TBL] [Abstract][Full Text] [Related]
17. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Witzgall H; Lorenz R; von Werder K; Weber PC Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312 [TBL] [Abstract][Full Text] [Related]
19. The antihypertensive effect of dietary potassium chloride loading in rats with adrenal regeneration hypertension. Milmer KE; Bennett T; Gardiner SM Clin Sci (Lond); 1984 Feb; 66(2):129-40. PubMed ID: 6692649 [TBL] [Abstract][Full Text] [Related]
20. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine? Coruzzi P J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]